Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling
雷帕霉素通过抑制自分泌信号传导,在体内对原发性渗出性淋巴瘤(PEL)细胞系有效。
期刊:Blood
影响因子:23.1
doi:10.1182/blood-2006-06-028092
Sin, Sang-Hoon; Roy, Debasmita; Wang, Ling; Staudt, Michelle R; Fakhari, Farnaz D; Patel, Dhavalkumar D; Henry, David; Harrington, William J Jr; Damania, Blossom A; Dittmer, Dirk P